Tag: ANDA patent challenge
Jan, 20 2026
Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Brand-Name Patents
Paragraph IV certifications let generic drug makers legally challenge brand-name patents before launch. This Hatch-Waxman Act tool drives down drug prices by enabling early generic entry - if the challenger wins, they get 180 days of exclusive sales.